I

Integer Holdings Corp
NYSE:ITGR

Watchlist Manager
Integer Holdings Corp
NYSE:ITGR
Watchlist
Price: 86.81 USD 3.75%
Market Cap: $3B

EV/GP

8.1
Current
16%
Cheaper
vs 3-y average of 9.6

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
8.1
=
Enterprise Value
$4.2B
/
Gross Profit
$507.7m

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
8.1
=
Enterprise Value
$4.2B
/
Gross Profit
$507.7m

Valuation Scenarios

Integer Holdings Corp is trading below its 3-year average

If EV/GP returns to its 3-Year Average (9.6), the stock would be worth $103.03 (19% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-37%
Maximum Upside
+22%
Average Downside
4%
Scenario EV/GP Value Implied Price Upside/Downside
Current Multiple 8.1 $86.81
0%
3-Year Average 9.6 $103.03
+19%
5-Year Average 9.9 $105.61
+22%
Industry Average 5.2 $55.03
-37%
Country Average 6.5 $69.58
-20%

Forward EV/GP
Today’s price vs future gross profit

Not enough data available to calculate forward EV/GP

Peer Comparison

All Multiples
EV/GP
P/E
All Countries
Close
Market Cap EV/GP P/E
US
Integer Holdings Corp
NYSE:ITGR
2.9B USD 8.1 29
US
Intuitive Surgical Inc
NASDAQ:ISRG
161.2B USD 23.4 56.5
US
Abbott Laboratories
NYSE:ABT
158.6B USD 6.2 25.1
US
Stryker Corp
NYSE:SYK
120.5B USD 8.2 37.4
IE
Medtronic PLC
NYSE:MDT
101.9B USD 5.3 22.3
US
Boston Scientific Corp
NYSE:BSX
84.8B USD 6.6 23.7
US
Edwards Lifesciences Corp
NYSE:EW
47.2B USD 8.9 43.3
DE
Siemens Healthineers AG
XETRA:SHL
38.3B EUR 5.2 18.5
US
IDEXX Laboratories Inc
NASDAQ:IDXX
44.1B USD 16.9 42.1
US
Becton Dickinson and Co
NYSE:BDX
41.4B USD 5.7 24
US
Resmed Inc
NYSE:RMD
30.9B USD 9.1 20.8

Market Distribution

In line with most companies in the United States of America
Percentile
59th
Based on 9 428 companies
59th percentile
8.1
Low
0 — 4.2
Typical Range
4.2 — 10.6
High
10.6 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 4.2
Median 6.5
70th Percentile 10.6
Max 1 764 211.7

Integer Holdings Corp
Glance View

Integer Holdings Corporation, a prominent player in the medical device industry, has carved a significant niche by aligning innovation with robust manufacturing capabilities. Founded as a collaborative effort between technical ingenuity and healthcare innovation, Integer primarily engages in the design and production of medical devices and components that are instrumental for the med-tech sector. It serves a diverse clientele that ranges from large healthcare conglomerates to emerging med-tech companies. The company operates through two main segments: Medical and Non-Medical. In the Medical division, Integer excels by providing critical components used in cardiac rhythm management, neuromodulation, and vascular access. It thrives on the premise that precision in manufacturing and innovation are key to producing reliable and effective medical solutions, ensuring that they meet stringent regulatory standards. What truly propels Integer’s financial engine is its commitment to operational excellence and strategic partnerships. By integrating vertically across its production processes, Integer achieves cost efficiencies that allow it to offer competitive pricing without sacrificing quality. Moreover, the company extends its influence through strategic partnerships with prominent healthcare providers, thereby securing long-term contracts and steady revenue streams. This model is supplemented by its Non-Medical segment, where Integer provides high-reliability components for energy, military, and environmental applications. These ventures not only diversify its revenue portfolio but also bolster its resilience against market volatility. Integer’s growth narrative is underscored by a relentless focus on research and development, which facilitates continuous product enhancement and keeps it at the forefront of technological advancement in the medical device industry. Through these strategies, Integer Holdings Corporation not only sustains its market position but also expands its role as a critical enabler in the global healthcare landscape.

ITGR Intrinsic Value
112.9 USD
Undervaluation 23%
Intrinsic Value
Price $86.81
I
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett